Navigation Links
Tylenol Liver Damage Lawyers Are Now Available through Resource4thePeople

(PRWEB) February 10, 2013

Resource4thePeople announced today that in the aftermath of the federal court system being petitioned* to group together lawsuits over serious liver problems alleged to have been caused by Tylenol pain-killers, it is providing victims access to lawyers offering free consultations.

These consultations can provide legal options to men, women and children who allegedly have suffered liver damage or failure due to their use of Tylenol and other products containing the ingredient acetaminophen.

Legal assistance also is available to those who may have lost a loved one and may be seeking information about the facts involved in a wrongful death.

“This announcement is being made because the number of cases involving Tylenol and other pain-killers containing acetaminophen is increasing and the U.S. Food and Drug Administration also has identified liver failure cases stemming from the pain-killers,” said Resource4thePeople.

The organization also is stepping up its efforts to make the public more aware of dosing problems that can exist with the use of Tylenol and other acetaminophen-based medications because many people may not be aware of these dangers as cited in the following health warning issued by the FDA:

“Acetaminophen is the generic name of a drug found in many common brand name OTC products such as Tylenol, as well as prescription products such as Vicodin and Percocet. Acetaminophen is an important drug, and its effectiveness in relieving pain and fever is widely known. This drug is generally considered safe when used according to the directions on its labeling. But taking more than the recommended amount can cause liver damage, ranging from abnormalities in liver function blood tests, to acute liver failure, and even death.”*

Resource4thePeople is also providing an information bank in which recent developments in the Tylenol litigation and information about acetaminophen products from medical researchers, news media and the FDA are posted at:

The recent petition to the United States Judicial Panel on Multidistrict Litigation was made by lawyers for 28 plaintiffs who have filed product liability lawsuits claiming that their use of Tylenol caused them to suffer liver damage or failure, according to a report in The Pennsylvania Record, the state’s legal journal.***

The Record reported that attorneys for the plaintiffs requested that the 28 cases currently pending against McNeil PPC Inc., McNeil Consumer Healthcare and Johnson & Johnson be coordinated and consolidated at the federal courthouse in Philadelphia.

“All of the products liability cases referenced by the plaintiffs’ lawyers allege that McNeil marketed and sold its over-the-counter Tylenol products in a manner that concealed the margin of risk of liver toxicity and liver failure,” the Record reported from the filings.

The news site reported that a total of 21 of the 28 cases are currently pending in the U.S. District Court for the Eastern District of Pennsylvania, and although they were originally assigned randomly to various judges within that district, they have all since been reassigned by the court’s chief judge to U.S. District Judge Lawrence F. Stengel, reads the attorneys’ memorandum of law in support of their motion for transfer and coordination or consolidation.

The Record also reported that other Tylenol liver damage actions have been filed in eight different federal courts in Mississippi, California, New York, Florida, New Jersey and Massachusetts.

In a 2011 Drug Safety Communication about pain-killers containing acetaminophen, the FDA announced to the public that Tylenol and other drug manufacturers were being asked to limit the strength of acetaminophen in prescription drug products out of concern about liver problems.***

Soon afterward, McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson, was among the companies announcing that it was reducing the recommended maximum daily dose of its Tylenol products.

Resource4thePeople is also announcing its concerns that many people may not be aware that the dosage requirements have been lowered by the FDA and notes that in this flu season warnings are once again being issued about overusing the medication.

In the interest of public health, Resource4thePeople is reminding consumers that because this is the middle of of the flu season many people may be using acetaminophen to treat their conditions and may not be aware of dosing recommendations.

Acetaminophen is contained in many of the most popular cold and flu remedies, aids for sleeping, relief mixtures for headaches as well as being an ingredient in prescribed pain-killers.

Consumer4thePeople is urging consumers to complete familiarize themselves with the warning labels on such medications because the FDA has ordered several changes in the levels of acetaminophen that are recommended, particularly based on age.

The FDA also has warned that patients who have excessive amounts of acetaminophen in their body over an extended period of time or even on just one occasion may put themselves at risk of suffering these life-threatening liver problems.*****

About 100 people in the United States die annually of accidental acetaminophen poisoning and another 15,000 end up in the emergency rooms from unknowingly taking too much, according to Dr. William Lee, director of the Clinical Center for Liver Diseases at the University of Texas Southwestern Medical Center in Dallas.****

The average adult should avoid more than 4,000 milligrams of acetaminophen per day, the equivalent of eight extra-strength tablets, and no more than 2,000 mg to 3,000 mg for those with liver problems like hepatitis or for those who drink regularly, Lee said in an interview with UPI.


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Tylenol Overdose Can Be Deadly for a Child
2. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
3. CT Scans Deliver More Radiation to Obese People: Study
4. Modest alcohol consumption lowers risk and severity of liver disease
5. Childhood Obesity May Raise Odds of Adult Liver Cancer
6. UNC study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
7. Combination of 2 drugs reverses liver tumors
8. New guidelines deliver concise messages for implementing cardiovascular prevention
9. Liver fat gets a wake-up call that maintains blood sugar levels
10. Hepatitis C Causing Liver Damage in Greater Numbers: Study
11. Body Building, Diet Supplements Linked to Liver Damage: Study
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Inevitably when people think Thanksgiving, they ... to buy during the Black Friday and Cyber Monday massage chair sales ... the Internet high and low to find the best massage chair deals, they can ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... real-time eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean ... Nuclear Medicine tests directly from their electronic medical record (EMR) without the need ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu ... As a franchise owner, Somu now offers travelers, value and care based Travel ... private cruise sales, as well as, cabin upgrades and special amenities such as, ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug Delivery ... to integrate dose form selection in early phase drug development. The first of ... and bringing together the UK’s emerging life sciences companies, corporate partners, and investors, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical ... professionals and offered by healthcare staffing agency Aureus Medical Group . ... of October 2015 among those searching for healthcare jobs through the company’s website, ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ... demands kidney transplantation is expected to boost the market growth, ... organ transplantation. --> 3D bioprinting market is ... a new report by Grand View Research Inc. Rising prevalence ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... 2015 ) ... "2016 Future Horizons and Growth Strategies in ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, ... --> ) has announced ... Horizons and Growth Strategies in the French ...
Breaking Medicine Technology: